Gujarat Kidney And Super Speciality (NSE:GKSL) ROC %: 8.34% (As of Mar. 2026)


NSE:GKSL Gujarat Kidney And Super Speciality Ltd NSE:GKSL
18 GF Score
Price ₹129.23
! 3 Warning Signs
View Full Analysis

What is Gujarat Kidney And Super Speciality ROC %?

Gujarat Kidney And Super Speciality NSE:GKSL +0.83% 18 ROC % is 8.34% as of Mar. 2026. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Gujarat Kidney And Super Speciality's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 8.34%.

As of today (2026-06-27), Gujarat Kidney And Super Speciality's WACC % is 12.91%. Gujarat Kidney And Super Speciality's ROC % is 13.70% (calculated using TTM income statement data). Gujarat Kidney And Super Speciality generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.

Gujarat Kidney And Super Speciality  (NSE:GKSL) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Gujarat Kidney And Super Speciality's WACC % is 12.91%. Gujarat Kidney And Super Speciality's ROC % is 13.70% (calculated using TTM income statement data). Gujarat Kidney And Super Speciality generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Gujarat Kidney And Super Speciality ROC % Related Terms

Gujarat Kidney And Super Speciality ROC % Historical Data

* Premium members only.

The historical data trend for Gujarat Kidney And Super Speciality's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality ROC % Chart

Gujarat Kidney And Super Speciality Annual Data
Trend Mar23 Mar24 Mar25 Mar26
ROC %
14.13 20.85 15.44 11.48

Gujarat Kidney And Super Speciality Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Dec25 Mar26
ROC % Get a 7-Day Free Trial 20.59 7.42 43.66 19.97 8.34
NSE:GKSL
18GF Score
Gujarat Kidney And Super Speciality Ltd NSE:GKSL
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gujarat Kidney And Super Speciality ROC % Calculation

Gujarat Kidney And Super Speciality's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2026 is calculated as:

ROC % (A: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2025 ) + Invested Capital (A: Mar. 2026 ))/ count )
=222.403 * ( 1 - 20.83% )/( (769.535 + 2296.913)/ 2 )
=176.0764551/1533.224
=11.48 %

where

Invested Capital(A: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=912.94 - 93.772 - ( 50.545 - max(0, 327.738 - 377.371+50.545))
=769.535

Invested Capital(A: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2976.4 - 84.563 - ( 594.924 - max(0, 278.15 - 1045.88+594.924))
=2296.913

Gujarat Kidney And Super Speciality's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=191.624 * ( 1 - 0% )/( (0 + 2296.913)/ 1 )
=191.624/2296.913
=8.34 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0 - ( 0 - max(0, 0 - 0+0))
=0

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2976.4 - 84.563 - ( 594.924 - max(0, 278.15 - 1045.88+594.924))
=2296.913

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 8.34% mean?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a ROC % of 8.34% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Gujarat Kidney And Super Speciality and its competitors.
Is Gujarat Kidney And Super Speciality's ROC % too high?
Gujarat Kidney And Super Speciality's current ROC % is 8.34%. The Healthcare Providers & Services industry median ROC % is 3.06. Gujarat Kidney And Super Speciality's value of 8.34% is 172.5% above this industry median. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's ROC % compare to HCA and THC?
Gujarat Kidney And Super Speciality's ROC % of 8.34% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROC % is 3.06. Gujarat Kidney And Super Speciality's value of 8.34% is 172.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Healthcare Providers & Services company?
The median ROC % among Healthcare Providers & Services companies is 3.06, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gujarat Kidney And Super Speciality's current ROC % of 8.34% is 172.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Gujarat Kidney And Super Speciality and its competitors. For the Healthcare Providers & Services industry, the median ROC % is 3.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Kidney And Super Speciality's current ROC % is 8.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current ROC % of 8.34%. The current ROC % is 8.34% and 172.5% above the Healthcare Providers & Services industry median of 3.06. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current ROC % is 8.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gujarat Kidney And Super Speciality Business Description

Other Exchanges 544666:India
Address Jetalpur Road, Gokak Mill Compound, Plot No. 1, City Sarve No. 1537/A, Jetalpur Bridge, Anand Nagar, Haripura, Alkapuri, Vadodara, GJ, IND, 390 020
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score

Get the complete analysis for NSE:GKSL

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹129.23
Price